HP and metabolic dysfunction-associated steatohepatitis: For instance, the increased fucosylation level or different fucosylation forms in α-1-acid glycoprotein 1 (AGP1) and haptoglobin (HPT) could differentiate nonalcoholic steatohepatitis, cirrhosis from healthy controls, or nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.